Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H34O7 |
| Molecular Weight | 410.5012 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]3(O)C(=O)C[C@@](C)(O[C@]13C)C=C
InChI
InChIKey=OHCQJHSOBUTRHG-KGGHGJDLSA-N
InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1
| Molecular Formula | C22H34O7 |
| Molecular Weight | 410.5012 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Colforsin (NKH477) is a water-soluble forskolin derivative. NKH477, like forskolin, showed adenylate cyclase stimulant activity in guinea pig ventricular membrane but did not inhibit Na+, K(+)-ATPase or phosphodiesterase (PDE) activity. The compound was developed by a Japanese company Nippon Kayaku. Colforsin daropate, a prodrug of colforsin, is marketed in Japan for the treatment of acute heart failure under tradename Adehl.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2097167 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8612348 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Second messenger modulation of electrotonic coupling between region CA3 pyramidal cell axons in the rat hippocampus. | 2001-03-02 |
|
| Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport. | 2001-03-01 |
|
| Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor. | 2001-03 |
|
| Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells. | 2001-03 |
|
| Expression of tyrosinase-related protein 2/DOPAchrome tautomerase in the retinoblastoma. | 2001-03 |
|
| 3',5'-cyclic adenosine monophosphate regulates expression of synaptotagmin in neonatal sympathetic ganglia in vitro. | 2001-03 |
|
| Selective enhancement of l-type calcium currents by corticotropin in acutely isolated rat amygdala neurons. | 2001-03 |
|
| Vascular beta-adrenergic receptor system is dysfunctional after myocardial infarction. | 2001-03 |
|
| Adenosine signaling in outer medullary descending vasa recta. | 2001-03 |
|
| Regulation of slow wave frequency by IP(3)-sensitive calcium release in the murine small intestine. | 2001-03 |
|
| G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells. | 2001-03 |
|
| (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. | 2001-03 |
|
| Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts. | 2001-02-23 |
|
| Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. | 2001-02-16 |
|
| LDL downregulates CYP51 in porcine vascular endothelial cells and in the arterial wall through a sterol regulatory element binding protein-2-dependent mechanism. | 2001-02-16 |
|
| Opioid-induced adenylyl cyclase supersensitization in human embryonic kidney 293 cells requires pertussis toxin-sensitive G proteins other than G(i1) and G(i3). | 2001-02-16 |
|
| Intracellular pathways regulating ciliary beating of rat brain ependymal cells. | 2001-02-15 |
|
| Regulation of neuregulin expression in the injured rat brain and cultured astrocytes. | 2001-02-15 |
|
| Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1. | 2001-02-15 |
|
| GH mRNA levels are elevated by forskolin but not GH releasing hormone in GHRH receptor-expressing MtT/S somatotroph cell line. | 2001-02-14 |
|
| Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells. | 2001-02-13 |
|
| Involvement of K(ATP) channels in diethylstilbestrol-induced relaxation in rat aorta. | 2001-02-09 |
|
| The proteasome inhibitor MG132 promotes accumulation of the steroidogenic acute regulatory protein (StAR) and steroidogenesis. | 2001-02-09 |
|
| Cysteine residues in the D-galactose-H+ symport protein of Escherichia coli: effects of mutagenesis on transport, reaction with N-ethylmaleimide and antibiotic binding. | 2001-02-01 |
|
| Membrane depolarization mediates phosphorylation and nuclear translocation of CREB in vascular smooth muscle cells. | 2001-02-01 |
|
| Function of a truncated glucocorticoid receptor form at a negative glucocorticoid response element in the proopiomelanocortin gene. | 2001-02 |
|
| Rapid modulation of Na+/K+-ATPase activity in osmoregulatory tissues of a salmonid fish. | 2001-02 |
|
| The growth hormone-releasing hormone receptor: desensitisation following short-term agonist exposure. | 2001-02 |
|
| Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine. | 2001-02 |
|
| The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo. | 2001-02 |
|
| Differential actions of PKA and PKC in the regulation of glutamate release by group III mGluRs in the entorhinal cortex. | 2001-02 |
|
| Parathyroid hormone-induced up-regulation of connexin-43 messenger ribonucleic acid (mRNA) is mediated by sequences within both the promoter and the 3'untranslated region of the mRNA. | 2001-02 |
|
| Glucocorticoids protect against apoptosis induced by serum deprivation, cyclic adenosine 3',5'-monophosphate and p53 activation in immortalized human granulosa cells: involvement of Bcl-2. | 2001-02 |
|
| Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone in human granulosa-luteal cells. | 2001-02 |
|
| beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells. | 2001-02 |
|
| Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells. | 2001-01-26 |
|
| cAMP mediated upregulation of CYP2A5 in mouse hepatocytes. | 2001-01-26 |
|
| Relaxation of rat aorta by adenosine in diabetes with and without hypertension: role of endothelium. | 2001-01-19 |
|
| Inhibition of stimulated Jurkat cell adenosine 3',5'-cyclic monophosphate synthesis by the immunomodulatory compound HR325. | 2001-01-15 |
|
| Regulation of human neutrophil-mediated cartilage proteoglycan degradation by phosphatidylinositol-3-kinase. | 2001-01 |
|
| NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance. | 2001-01 |
|
| Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. | 2001-01 |
|
| Proline transport in MDCK cells expressing a mutant regulatory subunit of cAMP-dependent protein kinase. | 2001-01 |
|
| G protein and cAMP-dependent protein kinase mediate amyloid beta-peptide inhibition of neuronal glucose uptake. | 2001-01 |
|
| Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein. | 2001-01 |
|
| Relationships between lipolysis induced by various lipolytic agents and hormone-sensitive lipase in rat fat cells. | 2001-01 |
|
| Induced cytoskeletal changes in bovine pulmonary artery endothelial cells by resveratrol and the accompanying modified responses to arterial shear stress. | 2001 |
|
| Prostacyclin inhibits the production of MMP-9 induced by phorbol ester through protein kinase A activation, but does not affect the production of MMP-2 in Human cultured mesangial cells. | 2001 |
|
| Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-I in cultured craniofacial mesenchymal cells. | 2001 |
|
| Differential neuronal localizations and dynamics of phosphorylated and unphosphorylated type 1 inositol 1,4,5-trisphosphate receptors. | 2001 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:56:18 GMT 2025
by
admin
on
Mon Mar 31 17:56:18 GMT 2025
|
| Record UNII |
1F7A44V6OU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
151 (Number of products:123)
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
FORSKOLIN
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
SUB06798MIG
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
1283244
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
42471
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
m3730
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
X-63
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
DB02587
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
100000084245
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
266-410-9
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
D005576
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
375489
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
C166496
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
5326
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
47936
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
CHEMBL52606
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
1F7A44V6OU
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
357088
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
C075212
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
DTXSID8040484
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY | |||
|
66575-29-9
Created by
admin on Mon Mar 31 17:56:18 GMT 2025 , Edited by admin on Mon Mar 31 17:56:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |